At MMFT, one of the most eye opening moments for patients is this:
You can look fit…
Have a normal weight…
Even perform well…
and still carry high levels of visceral fat.
And that matters more than most people realize.
Because visceral fat isn’t just about metabolism or aesthetics.
It’s increasingly linked to cancer risk.
What Is Visceral Fat (And Why MMFT Measures It)
Visceral fat is the fat stored around your internal organs not the fat you can pinch, but the fat you can’t see.
Unlike subcutaneous fat, visceral fat is:
- Highly metabolically active
- Hormone disrupting
- Inflammatory
At MMFT, we measure it because it’s one of the clearest indicators of hidden health risk.
And increasingly, research is showing:
It may be a meaningful driver of cancer risk independent of weight or BMI.
The Link Between Visceral Fat and Cancer Risk
Recent large scale research has shown that visceral adipose tissue is associated with increased cancer risk even when controlling for BMI and waist circumference.
Translation:
You can be “normal weight” and still have elevated cancer risk if visceral fat is high.
Why does visceral fat increase cancer risk?
This is where things get interesting.
Visceral fat contributes to:
1) Chronic inflammation
It produces inflammatory signals that can promote tumor development.
2) Hormonal disruption
It affects insulin, estrogen, and other pathways tied to cancer growth.
3) A metabolically “high-risk” environment
It’s strongly linked to metabolic dysfunction, one of the underlying drivers of many cancers.
Some studies have even linked higher visceral fat levels to increased risk across multiple cancers, including:
- Colorectal
- Liver
- Kidney
- Breast
Here’s the Problem: You Won’t Feel It
Visceral fat doesn’t cause symptoms early.
It doesn’t show up as:
- Pain
- Fatigue
- Performance decline (at least initially)
Which means:
By the time something feels “off,” the process may already be advanced.
That’s why MMFT focuses so heavily on early detection of hidden risk.
So Where Do Galleri® and MRI Screening Come In?
Once you understand visceral fat as a cancer risk amplifier, the next logical question becomes:
Can we detect problems earlier, before symptoms or performance changes?
That’s where newer tools like Galleri® and MRI-based screening (Ezra-style) enter the conversation.
Galleri®: Looking for Cancer Signals in the Blood
Galleri is a multi-cancer early detection (MCED) test that analyzes circulating DNA in the blood to detect signals associated with cancer.
In the context of visceral fat:
If visceral fat increases risk, Galleri is attempting to detect:
early biological signals that something may already be developing
Key points:
- Blood based, non invasive
- Designed to detect multiple cancers
- Not FDA-approved (lab developed test)
- Positive results require follow up
It’s not a replacement for standard screening but potentially an additional layer of early insight.
MRI Screening: Looking Directly at Organs
MRI-based screening (like Ezra) takes a different approach:
Instead of looking for signals, it looks for structure.
In the context of visceral fat:
- Visceral fat surrounds key organs (liver, pancreas, kidneys)
- These are also common sites of obesity-related cancers
MRI allows us to:
visualize those organs directly
The MMFT Connection: Risk → Measurement → Action
Here’s where this all comes together.
Step 1: Identify risk
MMFT detects elevated visceral fat and metabolic dysfunction
Step 2: Ask the right question
Is there a gap in current screening for this patient?
Step 3: Consider additional tools (if appropriate)
- Galleri → biological signals
- MRI → structural insight
Step 4: Integrate, not isolate
No test stands alone. Everything is interpreted within your full health profile.
Why This Isn’t for Everyone
This is where Maze Health takes a very different approach than most.
If we offer Galleri or MRI screening, it will be:
✔ Only for current Maze patients
Because we need your full data MMFT results, labs, history, not just a snapshot.
✔ Clinically guided
We consider:
- Visceral fat levels
- Metabolic health
- Family history
- Age and overall risk
✔ Intentional
We don’t order tests just to “check more boxes.”
We ask:
Will this change what we do next?
A Smarter Way to Think About Cancer Risk
Most people think about cancer risk in binary terms:
“I have it” or “I don’t.”
But the reality is more like a spectrum:
- Genetics
- Lifestyle
- Metabolic health
- Body composition (especially visceral fat)
All contribute to where you fall.
MMFT helps define that position more clearly.
Advanced screening when appropriate helps refine it further.
Final Thought: The Hidden Layer of Performance Health
You can optimize:
- Strength
- Endurance
- Nutrition
- Hormones
But if you ignore visceral fat, you may be missing one of the most important drivers of long term risk.
And if you ignore early detection altogether?
You’re relying on symptoms to tell you something’s wrong.
At MMFT, we prefer a different approach:
Measure what matters
Identify risk early
Use the right tools when they actually add value
